Exelixis, Inc. (EXEL)
54.57
+0.49
(+0.91%)
USD |
NASDAQ |
Aug 24, 16:00
54.57
0.00 (0.00%)
After-Hours: 20:00
Exelixis Debt to Equity Ratio : 0.09 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.09 |
| March 31, 2026 | 0.0876 |
| December 31, 2025 | 0.093 |
| September 30, 2025 | 0.0817 |
| June 30, 2025 | 0.0884 |
| March 31, 2025 | 0.0878 |
| December 31, 2024 | 0.0962 |
| September 30, 2024 | 0.0855 |
| June 30, 2024 | 0.0934 |
| March 31, 2024 | 0.0947 |
| December 31, 2023 | 0.0953 |
| September 30, 2023 | 0.0813 |
| June 30, 2023 | 0.077 |
| March 31, 2023 | 0.0732 |
| December 31, 2022 | 0.0835 |
| September 30, 2022 | 0.0642 |
| June 30, 2022 | 0.0673 |
| March 31, 2022 | 0.0221 |
| December 31, 2021 | 0.0255 |
| September 30, 2021 | 0.0247 |
| June 30, 2021 | 0.0261 |
| March 31, 2021 | 0.0276 |
| December 31, 2020 | 0.0277 |
| September 30, 2020 | 0.0257 |
| June 30, 2020 | 0.0264 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0274 |
| December 31, 2019 | 0.0301 |
| September 30, 2019 | 0.0165 |
| June 30, 2019 | 0.017 |
| March 31, 2019 | 0.0144 |
| December 31, 2018 | 0.0117 |
| September 30, 2018 | 0.0002 |
| June 30, 2018 | 0.0266 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.9465 |
| December 31, 2016 | 2.117 |
| September 30, 2016 | 5.960 |
| June 30, 2016 | -2.128 |
| March 31, 2016 | -2.492 |
| December 31, 2015 | -2.968 |
| September 30, 2015 | -5.091 |
| June 30, 2015 | -1.973 |
| March 31, 2015 | -2.510 |
| December 31, 2014 | -3.150 |
| September 30, 2014 | -6.071 |
| June 30, 2014 | 107.61 |
| March 31, 2014 | 4.799 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions, Inc. | 1.723 |
| Madrigal Pharmaceuticals, Inc. | 0.664 |
| United Therapeutics Corp. | 0.00 |
| AbbVie, Inc. | -11.93 |
| Tonix Pharmaceuticals Holding Corp. | 0.0057 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.494B |
| Total Liabilities (Quarterly) | 650.47M |
| Shareholders Equity (Quarterly) | 1.844B |
| Current Ratio | 3.456 |
| Net Debt Paydown Yield | 0.03% |